CPC A61K 31/435 (2013.01) [A61K 31/4745 (2013.01); A61P 35/00 (2018.01)] | 16 Claims |
1. A method for treating cancer in a subject in need thereof, comprising:
a. oral administration of irinotecan at an amount of about 5 mg/m2 to about 10 mg/m2, about 15 mg/m2, about 20 m2, about 25 mg/m2, or about 30 mg/m2 to the subject once a day and for 1-7 times a week; and
b. oral administration of Compound A:
to the subject once a day and for 1-7 times a week, and
wherein Compound A is administered simultaneously with or prior to the irinotecan.
|